Pages that link to "Q33448324"
Jump to navigation
Jump to search
The following pages link to A phase I clinical trial of recombinant human tumor necrosis factor (Q33448324):
Displaying 36 items.
- Human malarial disease: a consequence of inflammatory cytokine release (Q21034098) (← links)
- The Janus Face of Death Receptor Signaling during Tumor Immunoediting (Q28070036) (← links)
- Tumor necrosis factor or tumor promoting factor? (Q34568701) (← links)
- Muscle-derived interleukin-6: lipolytic, anti-inflammatory and immune regulatory effects (Q35104956) (← links)
- The pathophysiology of falciparum malaria (Q35187770) (← links)
- Systemic use of tumor necrosis factor alpha as an anticancer agent (Q35640180) (← links)
- Dual role of tumor necrosis factor-alpha in angiogenesis (Q35830630) (← links)
- Pathogenesis of malaria and clinically similar conditions (Q35838590) (← links)
- Tumor necrosis factor alpha/cachectin stimulates eosinophil oxidant production and toxicity towards human endothelium (Q36351266) (← links)
- Circadian dynamics of tumor necrosis factor alpha (cachectin) lethality (Q36363709) (← links)
- A comparison of the Antileukaemic Effects of Recombinant Human Tumour Necrosis Factor-alpha and its Muteins on Leukaemia L1210 and Leukaemia P388 in Mice (Q36627658) (← links)
- Targeting death-inducing receptors in cancer therapy (Q36832154) (← links)
- Combination of Gold Nanoparticle-Conjugated Tumor Necrosis Factor-α and Radiation Therapy Results in a Synergistic Antitumor Response in Murine Carcinoma Models. (Q37068894) (← links)
- Death receptors as targets for anti-cancer therapy (Q37390893) (← links)
- Selective CDK9 inhibition overcomes TRAIL resistance by concomitant suppression of cFlip and Mcl-1. (Q37578817) (← links)
- Rationale for immunotherapy of renal cell carcinoma (Q37803895) (← links)
- Tumor necrosis factor: an update on basic research and clinical applications (Q37965274) (← links)
- Targeting of the tumor necrosis factor receptor superfamily for cancer immunotherapy (Q38120535) (← links)
- The novel SMAC mimetic birinapant exhibits potent activity against human melanoma cells (Q39195579) (← links)
- Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo (Q39345885) (← links)
- A phase IIa study of rhLTα-Da in combination with cisplatin and fluorouracil for patients with metastatic esophageal squamous cell carcinoma or gastric adenocarcinoma (Q40085069) (← links)
- Cloning, expression and characterization of biologically active feline tumour necrosis factor-alpha. (Q40686915) (← links)
- A phase I study of local treatment of liver metastases with recombinant tumour necrosis factor (Q40738876) (← links)
- Effect of pyridoxine on tumor necrosis factor activitiesin vitro (Q41651824) (← links)
- Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest (Q42110300) (← links)
- High serum levels of TNF-α after its administration for isolation perfusion of the limb (Q42150777) (← links)
- Cellular and cytokine responses of the human central nervous system to intracranial administration of tumor necrosis factor α for the treatment of malignant gliomas (Q42482850) (← links)
- Role of tumour necrosis factor in the tumour-necrotizing activity of agents with diverging toxicity (Q43915289) (← links)
- Characterization of a tumor necrosis factor-alpha inhibitor activity in cancer patients (Q45699743) (← links)
- The advent of the cytokine storm (Q47834672) (← links)
- Anti-cancer therapy with TNFα and IFNγ: A comprehensive review. (Q52683804) (← links)
- Tumor necrosis factor-α is associated with positive lymph node status in patients with recurrence of colorectal cancer-indications for anti-TNF-α agents in cancer treatment. (Q53084304) (← links)
- Tumour necrosis factor and cancer (Q61819217) (← links)
- Regional biologic therapy. Hepatic arterial infusion of recombinant human tumor necrosis factor in patients with liver metastases (Q67720624) (← links)
- Differential sensitivity of renal cell carcinoma xenografts towards therapy with interferon-alpha, interferon-gamma, tumor necrosis factor and their combinations (Q67993236) (← links)
- Depletion of tumor necrosis factor-alpha in mice by Nyctanthes arbor-tristis (Q73397019) (← links)